Literature DB >> 26218140

Eosinophils and IL-33 Perpetuate Chronic Inflammation and Fibrosis in a Pediatric Population with Stricturing Crohn's Ileitis.

Joanne C Masterson1, Kelley E Capocelli, Lindsay Hosford, Kathryn Biette, Eóin N McNamee, Edwin F de Zoeten, Rachel Harris, Shahan D Fernando, Paul Jedlicka, Cheryl Protheroe, James J Lee, Glenn T Furuta.   

Abstract

BACKGROUND: Fibrostenosis and stricture are well-recognized endpoints in Crohn's disease (CD). We hypothesized that stricturing CD is characterized by eosinophilia and epithelial IL-33. We proposed that eosinophil exposure to IL-33 would perpetuate inflammatory chronicity and subsequent fibrostenosis.
METHODS: We performed a retrospective study of 74 children with inflammatory and stricturing ileal CD comparing clinicopathological features to immunohistochemical measures of eosinophilia and IL-33. To scrutinize eosinophil patterns, we developed a novel eosinophil peroxidase score encompassing number, distribution, and degranulation. Human eosinophils and intestinal fibroblasts were cultured with IL-33 and IL-13, and inflammatory and remodeling parameters were assessed. Antieosinophil therapy was also administered to the Crohn's-like ileitis model (SAMP1/SkuSlc).
RESULTS: Our novel eosinophil peroxidase score was more sensitive than H&E staining, revealing significant differences in eosinophil patterns, comparing inflammatory and stricturing pediatric CD. A significant relationship between ileal eosinophilia and complicated clinical/histopathological phenotype including fibrosis was determined. IL-33 induced significant eosinophil peroxidase secretion and IL-13 production. Exposure to eosinophils in the presence of IL-33, "primed" fibroblasts to increase proinflammatory cytokines (TNF-α, IL-1β, and IL-6), eosinophil-associated chemokines (CCL24 and CCL26), and IL-13Rα2 production. Production of fibrogenic molecules (collagen 1A2, fibronectin, and periostin) increased after exposure of "primed" fibroblasts to IL-13. Epithelial-IL-33 was increased in pediatric Crohn's ileitis and strongly associated with clinical and histopathological activity, ileal eosinophilia, and complicated fibrostenotic disease. SAMP1/SkuSlc eosinophil-targeted treatment resulted in significant improvements in inflammation and remodeling.
CONCLUSIONS: Our study of specimens from pediatric patients with ileal CD linked eosinophil patterns and IL-33 to fibrosis and suggested that these may contribute to the perpetuation of inflammation and subsequent stricture in pediatric CD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26218140      PMCID: PMC4567482          DOI: 10.1097/MIB.0000000000000512

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  57 in total

1.  Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.

Authors:  Luca Pastorelli; Rekha R Garg; Sharon B Hoang; Luisa Spina; Benedetta Mattioli; Melania Scarpa; Claudio Fiocchi; Maurizio Vecchi; Theresa T Pizarro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

2.  Interleukin-33 potentiates bleomycin-induced lung injury.

Authors:  Irina G Luzina; Pavel Kopach; Virginia Lockatell; Phillip H Kang; Ashish Nagarsekar; Allen P Burke; Jeffrey D Hasday; Nevins W Todd; Sergei P Atamas
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

3.  T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.

Authors:  Florian Rieder; Ilche Nonevski; Jie Ma; Zhufeng Ouyang; Gail West; Cheryl Protheroe; Giovanni DePetris; Anja Schirbel; James Lapinski; John Goldblum; Tracey Bonfield; Rocio Lopez; Karen Harnett; James Lee; Ikuo Hirano; Gary Falk; Piero Biancani; Claudio Fiocchi
Journal:  Gastroenterology       Date:  2014-01-28       Impact factor: 22.682

4.  Ultrastructural features of eosinophilic oesophagitis: impact of treatment on desmosomes.

Authors:  Kelley E Capocelli; Shahan D Fernando; Calies Menard-Katcher; Glenn T Furuta; Joanne C Masterson; Eric P Wartchow
Journal:  J Clin Pathol       Date:  2014-10-30       Impact factor: 3.411

5.  IL-33 markedly activates murine eosinophils by an NF-κB-dependent mechanism differentially dependent upon an IL-4-driven autoinflammatory loop.

Authors:  Carine Bouffi; Mark Rochman; Christopher B Zust; Emily M Stucke; Andrey Kartashov; Patricia C Fulkerson; Artem Barski; Marc E Rothenberg
Journal:  J Immunol       Date:  2013-09-16       Impact factor: 5.422

6.  Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially.

Authors:  Lisa A Spencer; Craig T Szela; Sandra A C Perez; Casey L Kirchhoffer; Josiane S Neves; Amy L Radke; Peter F Weller
Journal:  J Leukoc Biol       Date:  2008-10-07       Impact factor: 4.962

7.  Modulation of IL-33/ST2 system in postinfarction heart failure: correlation with cardiac remodelling markers.

Authors:  Jesús Sánchez-Más; Antonio Lax; María Del Carmen Asensio-López; Maria J Fernandez-Del Palacio; Luis Caballero; Giorgia Santarelli; James L Januzzi; Domingo A Pascual-Figal
Journal:  Eur J Clin Invest       Date:  2014-07       Impact factor: 4.686

Review 8.  Cytokines mediating the induction of chronic colitis and colitis-associated fibrosis.

Authors:  S Fichtner-Feigl; W Strober; E K Geissler; H-J Schlitt
Journal:  Mucosal Immunol       Date:  2008-11       Impact factor: 7.313

9.  Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis.

Authors:  Joanne C Masterson; Eóin N McNamee; Sophie A Fillon; Lindsay Hosford; Rachel Harris; Shahan D Fernando; Paul Jedlicka; Ryo Iwamoto; Elizabeth Jacobsen; Cheryl Protheroe; Holger K Eltzschig; Sean P Colgan; Makoto Arita; James J Lee; Glenn T Furuta
Journal:  Gut       Date:  2014-09-10       Impact factor: 23.059

10.  IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice.

Authors:  Dong Li; Rodrigo Guabiraba; Anne-Gaëlle Besnard; Mousa Komai-Koma; Majid S Jabir; Li Zhang; Gerard J Graham; Mariola Kurowska-Stolarska; Foo Y Liew; Charles McSharry; Damo Xu
Journal:  J Allergy Clin Immunol       Date:  2014-06-27       Impact factor: 10.793

View more
  26 in total

Review 1.  IL-33/ST2 Axis in Organ Fibrosis.

Authors:  Ourania S Kotsiou; Konstantinos I Gourgoulianis; Sotirios G Zarogiannis
Journal:  Front Immunol       Date:  2018-10-24       Impact factor: 7.561

2.  IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis.

Authors:  Carlo De Salvo; Xiao-Ming Wang; Luca Pastorelli; Benedetta Mattioli; Sara Omenetti; Kristine A Buela; Saleem Chowdhry; Rekha R Garg; Wendy A Goodman; Alex Rodriguez-Palacios; Dirk E Smith; Derek W Abbott; Fabio Cominelli; Giorgos Bamias; Wei Xin; James J Lee; Maurizio Vecchi; Theresa T Pizarro
Journal:  Am J Pathol       Date:  2016-02-22       Impact factor: 4.307

Review 3.  Immunological roles of intestinal mesenchymal cells.

Authors:  Robert J Nibbs; Kathy D McCoy; Allan Mcl Mowat; Carolyn A Thomson
Journal:  Immunology       Date:  2020-04-20       Impact factor: 7.397

4.  Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review.

Authors:  Ilyssa O Gordon; Dominik Bettenworth; Arne Bokemeyer; Amitabh Srivastava; Christophe Rosty; Gert de Hertogh; Marie E Robert; Mark A Valasek; Ren Mao; Satya Kurada; Noam Harpaz; Paula Borralho; Reetesh K Pai; Rish K Pai; Robert Odze; Roger Feakins; Claire E Parker; Tran Nguyen; Vipul Jairath; Mark E Baker; David H Bruining; J G Fletcher; Brian G Feagan; Florian Rieder
Journal:  Gastroenterology       Date:  2019-08-30       Impact factor: 22.682

Review 5.  ILC2s in infectious diseases and organ-specific fibrosis.

Authors:  Markus Kindermann; Lisa Knipfer; Imke Atreya; Stefan Wirtz
Journal:  Semin Immunopathol       Date:  2018-03-26       Impact factor: 9.623

6.  Clinical Implications of Pediatric Colonic Eosinophilia.

Authors:  Jacob Mark; Shahan D Fernando; Joanne C Masterson; Zhaoxing Pan; Kelley E Capocelli; Glenn T Furuta; Edwin F de Zoeten
Journal:  J Pediatr Gastroenterol Nutr       Date:  2018-05       Impact factor: 2.839

7.  Mucosal Eosinophilia Is an Independent Predictor of Vedolizumab Efficacy in Inflammatory Bowel Diseases.

Authors:  Erin M Kim; Cara Randall; Renee Betancourt; Staci Keene; Amy Lilly; Mark Fowler; Evan S Dellon; Hans H Herfarth
Journal:  Inflamm Bowel Dis       Date:  2020-07-17       Impact factor: 5.325

Review 8.  Intestinal eosinophils: multifaceted roles in tissue homeostasis and disease.

Authors:  G Coakley; H Wang; N L Harris
Journal:  Semin Immunopathol       Date:  2021-03-26       Impact factor: 9.623

Review 9.  Type 2 immunity in tissue repair and fibrosis.

Authors:  Richard L Gieseck; Mark S Wilson; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2017-08-30       Impact factor: 53.106

10.  The orphan nuclear receptor ROR alpha and group 3 innate lymphoid cells drive fibrosis in a mouse model of Crohn's disease.

Authors:  Bernard C Lo; Matthew J Gold; Michael R Hughes; Frann Antignano; Yanet Valdez; Colby Zaph; Kenneth W Harder; Kelly M McNagny
Journal:  Sci Immunol       Date:  2016-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.